This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bioverativ Therapeutics Inc.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Cherie Parkhurst-Lang: Innovator in Factor IX Formulations
Introduction
Cherie Parkhurst-Lang is a notable inventor based in Londonderry, NH (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of formulations for Factor IX, a crucial protein in blood coagulation.
Latest Patents
Cherie holds 2 patents related to lyophilized Factor IX formulations. Her latest patents focus on pre-lyophilization formulations, reconstituted formulations, and lyophilate powder compositions comprising a Factor IX (FIX) polypeptide. These inventions also include methods for lyophilization that enhance the stability of the FIX polypeptide when lyophilized.
Career Highlights
Cherie is currently employed at Bioverativ Therapeutics Inc., where she continues to innovate in the field of therapeutic formulations. Her work is pivotal in improving the stability and efficacy of Factor IX treatments, which are essential for patients with hemophilia.
Collaborations
Cherie collaborates with esteemed colleagues such as Brian M Thome and Brandon W Leveille, contributing to a dynamic research environment that fosters innovation and development in biopharmaceuticals.
Conclusion
Cherie Parkhurst-Lang's work in the development of Factor IX formulations exemplifies her commitment to advancing medical science and improving patient outcomes. Her contributions are invaluable in the field of biopharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile